Effectiveness of a warm-up programme to reduce injuries in youth volleyball players: a quasi-experiment.


Journal

British journal of sports medicine
ISSN: 1473-0480
Titre abrégé: Br J Sports Med
Pays: England
ID NLM: 0432520

Informations de publication

Date de publication:
Apr 2023
Historique:
accepted: 07 02 2023
medline: 3 4 2023
pubmed: 22 2 2023
entrez: 21 2 2023
Statut: ppublish

Résumé

To establish the effectiveness of the 'VolleyVeilig' programme on reducing injury rate, injury burden and injury severity in youth volleyball players. We conducted a quasi-experimental prospective study over one season of youth volleyball. After randomisation by competition region, we instructed 31 control teams (236 children, average age 12.58±1.66) to use their usual warm-up routine. The 'VolleyVeilig' programme was provided to 35 intervention teams (282 children, average age 12.90±1.59). This programme had to be used during each warm-up before training sessions and matches. We sent a weekly survey to all coaches, collecting data on each player's volleyball exposure and injuries sustained. Multilevel analyses estimated differences in injury rates and burden between both groups, and we used non-parametric bootstrapping to compare the differences in injury numbers and injury severity. We found an overall reduction in injury rates of 30% for intervention teams (HR 0.72; 95% CI 0.39 to 1.33). Detailed analyses revealed differences for acute (HR 0.58; 95% CI 0.34 to 0.97) and upper extremity injuries (HR 0.41; 95% CI 0.20 to 0.83). Compared with control teams, the intervention teams had a relative injury burden of 0.39 (95% CI 0.30 to 0.52) and a relative injury severity of 0.49 (95% CI 0.03 to 0.95). Only 44% of teams fully adhered to the intervention. We established that the 'VolleyVeilig' programme was associated with reduced acute and upper extremity injury rates and lower injury burden and severity in youth volleyball players. While we advise implementation of the programme, programme updates to improve adherence are needed.

Identifiants

pubmed: 36801807
pii: bjsports-2022-105425
doi: 10.1136/bjsports-2022-105425
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

464-470

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: EK was employed at the Dutch Consumer Safety Institute (VeiligheidNL). JdW was employed at the Dutch Volleyball Federation (Nevobo). VeiligheidNL and Nevobo own the 'VolleyVeilig' intervention.

Auteurs

Evert Verhagen (E)

Amsterdam Collaboration on Health & Safety in Sports, Department of Public and Occupational Health, Amsterdam Movement Sciences, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands e.verhagen@amsterdamumc.nl.

Ingrid Vriend (I)

Amsterdam Collaboration on Health & Safety in Sports, Department of Public and Occupational Health, Amsterdam Movement Sciences, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands.

Vincent Gouttebarge (V)

Section Sports Medicine, University of Pretoria, Pretoria, South Africa.
Amsterdam UMC location University of Amsterdam, Department of Orthopedic Surgery and Sports Medicine, Meibergdreef 9, Amsterdam, The Netherlands.
Amsterdam Collaboration on Health & Safety in Sports (ACHSS), IOC Research Center, Amsterdam, The Netherlands.
Amsterdam Movement Sciences, Musculoskeletal Health, Sports, Amsterdam, The Netherlands.

Ellen Kemler (E)

Dutch Consumer Safety Institute (VeligheidNL), Amsterdam, The Netherlands.

Jacqueline de Wit (J)

Dutch Volleyball Federation, Utrecht, The Netherlands.

Daniel Zomerdijk (D)

Amsterdam Collaboration on Health & Safety in Sports, Department of Public and Occupational Health, Amsterdam Movement Sciences, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands.

Joske Nauta (J)

Amsterdam Collaboration on Health & Safety in Sports, Department of Public and Occupational Health, Amsterdam Movement Sciences, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH